CYCS and colorectal cancer: Extension of these analyses to other colorectal cancer cell lines showed that exposure of RKO, RW2982 and SW403 cells to 10, 20 or 50 μM oxaliplatin resulted in a significant (P<0.01) increase in the number of cells showing Bax/cytochrome c re-localisation (Figure 3C).